Sign In
Buy ENTX
$1.22
-0.0300 (-2.40%)
At Close: Jun 03, 2026
Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer
12:00pm, Thursday, 21'st Nov 2019
Entera Bio Ltd. (ENTX) today announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan Lieber as its U.S.-based CFO. Mr. Lieber will be responsible for all inves
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
01:37pm, Monday, 18'th Nov 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Entera Bio to Announce Third Quarter 2019 Financial Results on Thursday, November 21, 2019
09:30pm, Thursday, 07'th Nov 2019
Entera Bio Ltd. (ENTX), announced today that it will report financial results for the third quarter and nine months ended September 30, 2019 before the U.S. financial markets open on Thursday, Novembe
NEW YORK , Oct. 7, 2019 /PRNewswire/ -- Equity research is published in the framework of Frost's Independent Equity Research Program. This type of equity research is trusted by investors as it is unbi
Entera Bio Reports Positive Results from a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism
12:00pm, Monday, 23'rd Sep 2019
Entera Bio Ltd. (ENTX) today announced the presentation of positive results from its pharmacokinetic (PK) and pharmacodynamic (PD) study in patients with hypoparathyroidism treated with its oral para
Such Is Life: How Entera Bio (NASDAQ:ENTX) Shareholders Saw Their Shares Drop 51%
03:36pm, Thursday, 19'th Sep 2019
Investing in stocks comes with the risk that the share price will fall. Unfortunately, shareholders of Entera Bio Ltd...
Entera Bio to Present at the Ladenburg Thalmann 2019 Healthcare Conference
12:00pm, Thursday, 19'th Sep 2019
Entera Bio Ltd. (ENTX) announced today that Adam Gridley, CEO, and Dr. Phillip Schwartz, President of R&D;, will present at the Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, September 24,
Entera Bio Reports Second Quarter 2019 Financial Results and Provides Operating Update
11:00am, Tuesday, 20'th Aug 2019
Phase 2 study for oral PTH in osteoporosis was initiated in June 2019; Data expected in 2020Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Results.
Entera Bio to Announce Second Quarter and Six Months ended June 30, 2019 Financial Results on Tuesday, August 20, 2019
11:00am, Thursday, 15'th Aug 2019
The Company will host a conference call at 8:30 am Eastern Time to discuss the results and provide a corporate update. A live audio webcast of the presentation will be available via the “Investor
Entera Bio Appoints Adam Gridley as Chief Executive Officer
12:00pm, Monday, 05'th Aug 2019
JERUSALEM, Israel, Aug. 05, 2019 -- Entera Bio Ltd. (Nasdaq: ENTX), announced today the appointment of Adam Gridley as Chief Executive Officer, effective immediately. Phillip.
